MCL1 and neoplasm: Once again, while BCL-xL upregulation was observed in specific tumors in both tumor groups (Figure 8C), the BCL-xL/MCL-1 ratio was significantly increased, both in stage I-II and in stage III-IV tumors (Figure 8D).